| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |